BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32011505)

  • 1. Prolonged cholestasis following endoscopic retrograde cholangiopancreatography, a rare complication of contrast agent induced liver injury: A case report and literature review.
    Lin CK; Huang WC
    Medicine (Baltimore); 2020 Jan; 99(3):e18855. PubMed ID: 32011505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged cholestasis following successful removal of common bile duct stones: beware patients on estrogen therapy.
    Dunn JM; McNair A
    World J Gastroenterol; 2007 Dec; 13(46):6277-80. PubMed ID: 18069774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worsening cholestasis and possible cefuroxime-induced liver injury following "successful" therapeutic endoscopic retrograde cholangiopancreatography for a distal common bile duct stone: a case report.
    Niriella MA; Kumarasena RS; Dassanayake AS; Pathirana A; de Silva Hewavisenthi J; de Silva HJ
    J Med Case Rep; 2016 Dec; 10(1):371. PubMed ID: 28003028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual case of prolonged post-endoscopic retrograde cholangiopancreatography jaundice.
    Tziatzios G; Gkolfakis P; Papanikolaou IS; Dimitriadis G; Triantafyllou K
    Hepatobiliary Pancreat Dis Int; 2016 Apr; 15(2):220-2. PubMed ID: 27020640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is ursodeoxycholic acid detrimental in obstructive cholestasis? A propos of a case of malignant biliary obstruction.
    Bessone F; Roma MG
    Ann Hepatol; 2016; 15(3):442-7. PubMed ID: 27049500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gilbert syndrome combined with prolonged jaundice caused by contrast agent: Case report.
    Qian JD; Hou FQ; Wang TL; Shao C; Wang GQ
    World J Gastroenterol; 2018 Apr; 24(13):1486-1490. PubMed ID: 29632429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin-induced prolonged cholestasis with bile duct damage.
    Merli M; Bragazzi MC; Giubilo F; Callea F; Attili AF; Alvaro D
    Clin Drug Investig; 2010; 30(3):205-9. PubMed ID: 20155993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic recurrent pancreatitis: long-term results after ERCP, endoscopic sphincterotomy, or ursodeoxycholic acid treatment.
    Testoni PA; Caporuscio S; Bagnolo F; Lella F
    Am J Gastroenterol; 2000 Jul; 95(7):1702-7. PubMed ID: 10925971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic cholestasis associated with Turner's syndrome.
    Floreani A; Molaro M; Baragiotta A; Naccarato R
    Digestion; 1999; 60(6):587-9. PubMed ID: 10545732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
    Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
    Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined endoscopic and ursodeoxycholic acid treatment of biliary cast syndrome in a non-transplant patient.
    Katsinelos P; Kountouras J; Chatzimavroudis G; Zavos C; Pilpilidis I; Paroutoglou G
    World J Gastroenterol; 2008 Sep; 14(33):5223-5. PubMed ID: 18777601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of biliary stenting combined with ursodeoxycholic acid and terpene treatment on retained common bile duct stones in elderly patients: a multicenter study.
    Han J; Moon JH; Koo HC; Kang JH; Choi JH; Jeong S; Lee DH; Lee MS; Kim HG
    Am J Gastroenterol; 2009 Oct; 104(10):2418-21. PubMed ID: 19568225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of clogging of biliary stents by administration of levofloxacin and ursodeoxycholic acid].
    Sciumè C; Geraci G; Pisello F; Facella T; Li Volsi F; Modica G
    Chir Ital; 2004; 56(6):831-7. PubMed ID: 15771038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ursodeoxycholic acid treatment shortens the course of cholestasis in two patients with benign recurrent intrahepatic cholestasis].
    Nicolás I; Pons JA; Vargas A; Gallardo F; Albaladejo A; Nicolás JM
    Gastroenterol Hepatol; 2003; 26(7):421-3. PubMed ID: 12887856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy.
    Kondrackiene J; Beuers U; Kupcinskas L
    Gastroenterology; 2005 Sep; 129(3):894-901. PubMed ID: 16143129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment of intrahepatic cholestasis in chronic diseases of the liver].
    Golovanova EV; Petrakov AV
    Ter Arkh; 2011; 83(2):33-9. PubMed ID: 21516847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colestimide: the efficacy of a novel anion-exchange resin in cholestatic disorders.
    Matsuzaki Y
    J Gastroenterol Hepatol; 2002 Nov; 17(11):1133-5. PubMed ID: 12453270
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased intercellular adhesion molecule-1 serum concentration in cholestasis.
    Polzien F; Ramadori G
    J Hepatol; 1996 Dec; 25(6):877-86. PubMed ID: 9007716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholestasis from ticlopidine: two clinical cases].
    Varvello L; Arnò C; Coggiola M; Ramassotto E; Pascale C
    Ann Ital Med Int; 2002; 17(4):252-5. PubMed ID: 12532564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cholestatic acute hepatitis induced by amoxycillin-clavulanic acid combination. Role of ursodeoxycholic acid in drug-induced cholestasis].
    Barrio J; Castiella A; Lobo C; Indart A; López P; García-Bengoechea M; Cosme A; Arenas JI
    Rev Esp Enferm Dig; 1998 Jul; 90(7):523-6. PubMed ID: 9741209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.